(PR-inside.com) Biosystems International (BSI) is a biotechnology company which develops protein biomarker. The company's activities include protein biomarker research and development using monoclonal antibody based proteomics technology. Its products include PlasmaScan and Quantiplasma libraries. BSI's PlasmaScan consists of PlasmaScan 80 / PlasmaScan 380 antibody arrays which include 80 and 380 different mABs each reacting with diverse epitopes of the human plasma proteome. BSI develops microarrays for pharmaceutical and academic research. Its antibody microarrays will facilitate the discovery of novel biomarkers in the life sciences, pharmaceutical and health science sectors. The company offers blood-based diagnostics for cancer and chronic diseases. BSI is ..